For over a decade, the McGill University Health Centre (MUHC) has been at the forefront of aortic valve innovation, advancing ...

For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform ... Among its selling points are the ...

“That’s the key.” By his side, Cardiologist Dr. Stan Watkins explained how it all happens. “It’s a stent, basically, that’s ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial’s ...

Get Instant Summarized Text (Gist) A new transcatheter valve, the Trilogy system, has demonstrated safety and efficacy in treating aortic regurgitation, with a one-year mortality rate of 8.1% ...

Cardiovascular surgeons at the WVU Heart and Vascular Institute are the first in the state to implant the GORE Ascending Stent Graft as part of a new clinical trial to treat complex and potentially ...

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure. While ...

Hemodynamic analysis based on computational fluid dynamics (CFD) modelling is expected to improve risk stratification for patients with aortic aneurysms and dissections. However, the parameter ...

Transcatheter aortic valve replacement (TAVR) has paved the way for minimally invasive approaches ... It provides faster recovery, fewer complications, and a substantial enhancement in quality of life ...

Lp(a) (lipoprotein(a)) is an independent risk factor for calcific aortic valve stenosis (CAVS). Whether patients with CAVS and high Lp(a) levels are at higher risk of valvular or cardiovascular events ...